- 扫描 ID：
- e3a68be7-918c-461d-b248-22fab87b4a12已完成
- 提交的 URL：
- https://hq.pharmaessentia.com/
- 报告完成时间：
链接 · 找到 10 个
从页面中识别出的传出链接
| 链接 | 文本 |
|---|---|
| https://jp.pharmaessentia.com | Japan |
| https://www.pharmaessentia.com/home-tw/ | US |
| http://www.pharmaessentia.co.kr/ | Korea |
| https://www.pancohc.com.tw/ | Panco |
| https://pirc.pharmaessentia.com/ | PIRC |
| http://www.pharmaessentia-esg.com/en | ESG |
| https://www.pharmaessentiajapan.com/ | 日本語 |
| http://www.pharmaessentia-tpe.com/en/pipeline | Development Pipeline |
| http://www.pharmaessentia-tpe.com/en/press_releases | Press Releases |
| https://www.creatop.com.tw | CREATOP. |
JavaScript 变量 · 找到 25 个
在页面窗口对象上加载的全局 JavaScript 变量是在函数外部声明的变量，可以从当前范围内的代码中的任何位置访问
| 名称 | 类型 |
|---|---|
| 0 | object |
| onbeforetoggle | object |
| documentPictureInPicture | object |
| onscrollend | object |
| gtag | function |
| dataLayer | object |
| google_tag_manager | object |
| google_tag_data | object |
| GoogleAnalyticsObject | string |
| ga | function |
控制台日志消息 · 找到 1 条
记录到 Web 控制台的消息
| 类型 | 类别 | 记录 |
|---|---|---|
| warning | other |
|
HTML
页面的原始 HTML 正文
<!DOCTYPE html><!-- Global site tag (gtag.js) - Google Analytics --><html lang="en"><head><script type="text/javascript" async="" src="https://www.google-analytics.com/analytics.js"></script><script type="text/javascript" async="" src="https://www.googletagmanager.com/gtag/js?id=G-Y3KZCM5X6S&l=dataLayer&cx=c"></script><script async="" src="https://www.googletagmanager.com/gtag/js?id=UA-122835478-1"></script>
<script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-122835478-1');
</script>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="google-site-verification" content="6YuCyuVmjSgH4AXFGt-QNZZnXPZ8JhUFBLDwkfgPJiA">
<title>PharmaEssentia-Ropeginterferon alfa-2b,P1101,PV,polycythemia vera,new drug development,biologics,PIC/s GMP protein plant</title>
<base href="https://hq.pharmaessentia.com/">
<link rel="stylesheet" href="assets/css/style.min.css?202201061435">
<link rel="icon" type="image/png" href="assets/img/favicon.png">
<link href="assets/img/apple-icon-144x144.png" rel="apple-touch-icon" sizes="144x144">
<meta name="keywords" content="Ropeginterferon alfa-2b,PV,ET,orphan drug designation,P1101,HBV e+,HCV genotype II,Oraxol,biologics">
<meta name="description" content="PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis and other diseases. The Company’s world-class cGMP biologics facility in Taichung is certified by the Taiwan Food and Drug Administration (TFDA) and is designed and operated to be compliant with all U.S. FDA and EMA requirements. Ropeginterferon alfa-2b is a novel, long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties offering improved tolerability and convenience. Ropeginterferon alfa-2b was discovered by PharmaEssentia and it has Orphan Drug designation in the European Union and the United States of America. PharmaEssentia plans to commercialize ropeginterferon alfa-2b in North and South America and Asia. Ropeginterferon alfa-2b has been exclusively licensed the rights to AOP Orphan for European, CIS, and Middle Eastern markets in the field of Myeloproliferative Neoplasms (MPNs). ">
<meta name="author" content="PharmaEssentia-Ropeginterferon alfa-2b,P1101,PV,polycythemia vera,new drug development,biologics,PIC/s GMP protein plant">
<meta name="copyright" content="PharmaEssentia-Ropeginterferon alfa-2b,P1101,PV,polycythemia vera,new drug development,biologics,PIC/s GMP protein plant">
<meta property="og:title" content="PharmaEssentia-Ropeginterferon alfa-2b,P1101,PV,polycythemia vera,new drug development,biologics,PIC/s GMP protein plant">
<meta property="og:type" content="website">
<meta property="og:url" content="http://hq.pharmaessentia.com/">
<meta property="og:image" content="https://hq.pharmaessentia.com/assets/img/default.png">
<meta property="og:image:type" content="image/png">
<meta property="og:image:width" content="800">
<meta property="og:image:height" content="547">
<meta property="og:description" content="PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis and other diseases. The Company’s world-class cGMP biologics facility in Taichung is certified by the Taiwan Food and Drug Administration (TFDA) and is designed and operated to be compliant with all U.S. FDA and EMA requirements. Ropeginterferon alfa-2b is a novel, long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties offering improved tolerability and convenience. Ropeginterferon alfa-2b was discovered by PharmaEssentia and it has Orphan Drug designation in the European Union and the United States of America. PharmaEssentia plans to commercialize ropeginterferon alfa-2b in North and South America and Asia. Ropeginterferon alfa-2b has been exclusively licensed the rights to AOP Orphan for European, CIS, and Middle Eastern markets in the field of Myeloproliferative Neoplasms (MPNs). ">
<!--[if lt IE 9]>
<script src="assets/js/html5shiv.min.js"></script>
<![endif]-->
</head>
<body>
<header class="wrap-fs header" name="top">
<div class="header-wrap">
<section class="header-left mobile-hide">
<a href="en/contact" class="contact-pc"><span class="icon-contact"></span></a>
<form class="search-pc" id="searchpc" name="searchpc" onsubmit="chk_search(document.searchpc); return false;">
<input type="text" name="searchkey" placeholder="Keyword">
</form>
</section>
<section class="header-right mobile-hide">
<ul class="lan-pc">
<li><a><span class="icon-lan-pc"></span></a>
<ul>
<li class="zh"><a href="https://hq.pharmaessentia.com/tw">繁體中文</a></li>
<li class="us"><a href="https://hq.pharmaessentia.com/en">English</a></li>
<li class="jp"><a href="https://jp.pharmaessentia.com" target="_blank"></a></li>
</ul>
</li>
</ul>
<div class="other-link">
<ul>
<li><a href="https://www.pharmaessentia.com/home-tw/" target="_blank">US</a> </li>
<li><a href="https://jp.pharmaessentia.com" target="_blank">Japan</a></li>
<li><a href="http://www.pharmaessentia.co.kr/" target="_blank">Korea</a></li>
<li><a href="https://www.pancohc.com.tw/" target="_blank">Panco</a></li>
<li><a href="https://pirc.pharmaessentia.com/" target="_blank">PIRC</a></li>
</ul>
</div>
</section>
<a href="https://hq.pharmaessentia.com/en" class="logo block hidden">PharmaEssentia-Ropeginterferon alfa-2b,P1101,PV,polycythemia vera,new drug development,biologics,PIC/s GMP protein plant></a>
<span class="nav-toggle"><span>Mobile Button</span></span>
<a class="dsk-hide btn-search search-icon" href="javascript:void(0);">Search></a>
</div>
<nav class="nav wrap-fs">
<div class="nav-wrap">
<ul>
<li class="hassub">
<a href="javascript:void(0);"><span>About Us</span><i></i></a>
<div class="submenu">
<ul>
<li><a href="en/achievements"> Achievements</a></li>
<li><a href="en/about/Executives">Executives</a></li>
<li><a href="en/about/Partnership">Partnership</a></li>
<li><a href="en/about/Join-Us">Join Us</a></li>
<li><a href="en/about/Locations">Locations</a></li>
</ul>
</div>
</li>
<li class="hassub">
<a href="javascript:void(0);"><span>Capabilities</span><i></i></a>
<div class="submenu">
<ul>
<li class="hasthird"><span>R&D Center</span>
<ul class="thirdmenu">
<li><a href="en/pipeline">Pipeline</a></li>
<li><a href="en/rdcenter/Core-Technology">Core Technology </a></li>
<li><a href="en/rdcenter/2">R&D Focus </a></li>
</ul>
</li>
<li class="hasthird"><span>Manufacturing Site</span>
<ul class="thirdmenu">
<li><a href="en/manufacturing/Milestone">Milestone</a></li>
<li><a href="en/manufacturing/Facilities">Facilities </a></li>
<li><a href="en/manufacturing/Process-and-Critical-Equipment">Process and Critical Equipment</a></li>
</ul>
</li>
</ul>
</div>
</li>
<li class="hassub">
<a href="javascript:void(0);"><span>Focus</span> <i></i></a>
<div class="submenu">
<ul>
<li class="hasthird"><span>Hematology</span>
<ul class="thirdmenu">
<li><a href="en/hematology/P1101-in-PV">P1101 in PV</a></li>
<li><a href="en/hematology/P1101-in-ET">P1101 in ET</a></li>
</ul>
</li>
<li class="hasthird"><span>Infectious Diseases</span>
<ul class="thirdmenu">
<li><a href="en/infectious/A-Phase-Ib-trial-for-Sequential-Administration-of-P1101-and-Anti-PD1-in-Interferon-Naive-Adults-with-Chronic-Hepatitis-B-or-D-Infection">A Phase Ib trial for Sequential Administration of P1101 and Anti-PD1 in Interferon-Naive Adults with Chronic Hepatitis B or D Infection</a></li>
</ul>
</li>
<li class="hasthird"><span>Oncology</span>
<ul class="thirdmenu">
<li><a href="en/oncology/2">PD-1 in HCC Phase I/II (IIT)</a></li>
</ul>
</li>
<li><a href="en/resources">Publications</a></li>
</ul>
</div>
</li>
<li class="hassub">
<a href="en/patients">
Patients & Healthcare<i></i></a>
<div class="submenu">
<ul>
<li><a href="en/patients/Patients-Healthcare-Professionals">Patients & Healthcare Professionals</a></li>
<li><a href="en/patients/Medical-Information">Medical Information</a></li>
<li><a href="en/patients/Resources">Resources</a></li>
</ul>
</div>
</li>
<li class="hassub"><a href="javascript:void(0);">News<i></i></a>
<div class="submenu">
<ul>
<li><a href="en/news_latest">Latest News</a></li>
<li><a href="en/press_releases">Press Releases</a></li>
<li><a href="en/news_event">Events</a></li>
</ul>
</div>
</li>
<li class="hassub">
<a href="javascript:void(0);">
Investors<i></i></a>
<div class="submenu">
<ul>
<li><a href="en/ir_financial">Financial Information</a></li>
<li><a href="en/ir_shareholder">Shareholder’s Services</a></li>
<!-- <li><a href="en/ir_stock">Stock Information</a></li>
<li><a href="en/ir_news">Announcement</a></li> -->
<li><a href="en/ir_faq">FAQ</a></li>
<li><a href="en/ir_event">Events & Presentations</a></li>
<li><a href="en/ir_contact">Contact Us</a></li>
</ul>
</div>
</li>
<li class="">
<a href="http://www.pharmaessentia-esg.com/en" target="_blank">
ESG<i></i>
</a>
</li>
<li class="hassub">
<a href="javascript:void(0);">
Corporate Governance<i></i>
</a>
<div class="submenu">
<ul>
<li><a href="en/csr/Corporate-Governance-Structure">Corporate Governance Structure</a></li>
<li><a href="en/csr/Board-of-Directors">Board of Directors</a></li>
<li><a href="en/csr/Downloads-and-Interactions">Downloads</a></li>
</ul>
</div>
</li>
<!-- HR -->
<!-- <li class="hassub">
<a href="javascript:void(0);">
HR<i></i>
</a>
<div class="submenu">
<ul>
</ul>
</div>
</li> -->
<!-- <li class="dsk-hide hassub"><a href="javascript:void(0);">News</a>
<div class="submenu">
<ul>
<li><a href="en/news_latest">Latest News</a></li>
<li><a href="en/press_releases">Press Releases</a></li>
<li><a href="en/news_event">Events</a></li>
</ul>
</div>
</li> -->
<li class="dsk-hide"><a class="contact-icon" href="en/contact">Contact</a></li>
<li class="dsk-hide hassub"><a class="language" href="javascript:void(0);">Language</a>
<div class="submenu">
<ul>
<li class="zh"><a href="https://hq.pharmaessentia.com/tw">繁體中文</a></li>
<li class="us"><a href="https://hq.pharmaessentia.com/en">English</a></li>
<li class="jp"><a href="https://www.pharmaessentiajapan.com/" target="_blank">日本語</a></li>
</ul>
</div>
</li>
<li class="dsk-hide hassub"><a class="other_link" href="javascript:void(0);">Subsidiary</a>
<div class="submenu">
<ul>
<li><a href="https://www.pharmaessentia.com/home-tw/" target="_blank">US</a> </li>
<li><a href="https://jp.pharmaessentia.com" target="_blank">Japan</a></li>
<li><a href="http://www.pharmaessentia.co.kr/" target="_blank">Korea</a></li>
<li><a href="https://www.pancohc.com.tw/" target="_blank">Panco</a></li>
<li><a href="https://pirc.pharmaessentia.com/" target="_blank">PIRC</a></li>
</ul>
</div>
</li>
</ul>
</div>
</nav>
</header>
<div class="searchbar">
<div>
<form id="searchmo" name="searchmo" onsubmit="chk_search(document.searchmo); return false;">
<input type="text" name="searchkey" placeholder="Keyword">
</form>
</div>
</div>
<script>
function chk_search(obj){
var searchkey = obj.searchkey.value.trim();
if(searchkey == ""){
alert("Enter your keyword here"); return;
}else{
location.href = "https://hq.pharmaessentia.com/en/search/?searchkey="+searchkey;
}
}
</script>
<div class="page" id="index">
<div class="wrap-fs index-slider">
<div class="cover">
<a href="en/rdcenter/Core-Technology">
<div class="wrap slogan">
<div class="row no-gutters">
<div class="col-xl-5">
<h1>Ropeginterferon alfa-2b </h1>
<p>The predominantly single isomer long acting interferon alpha-2b<br></p>
<!-- <a class="wlbtn" href="en/rdcenter/Core-Technology" target="_self"></a> -->
</div>
</div>
</div>
</a>
</div>
<div class="tv">
<div class="fluid-width-video-wrapper"><iframe src="https://player.vimeo.com/video/333242842?autoplay=1&loop=1&title=0&byline=0&portrait=0" style="position:absolute;top:0;left:0;width:100%;height:100%;" frameborder="0" allow="autoplay; fullscreen" allowfullscreen=""></iframe><script src="https://player.vimeo.com/api/player.js"></script></div>
</div>
</div>
<div class="wrap icut">
<div class="row">
</div>
</div>
<div class="wrap-fs">
<div class="row no-gutters">
<a class="ilnk col-sm-6" href="http://www.pharmaessentia-tpe.com/en/pipeline" target="_self">
<div class="images" style="background-image: url(/uploads/images/index/link01.jpg);"></div>
<div class="txt"><h2>Development Pipeline<span></span></h2></div>
</a>
<a class="ilnk col-sm-6" href="http://www.pharmaessentia-tpe.com/en/press_releases" target="_self">
<div class="images" style="background-image: url(/uploads/images/index/link02.jpg);"></div>
<div class="txt"><h2>Press Releases<span></span></h2></div>
</a>
</div>
</div>
<div class="wrap-fs breadcrumb">
<div class="wrap">
<ol itemscope="" itemtype="http://schema.org/BreadcrumbList">
<li itemprop="itemListElement" itemscope="" itemtype="http://schema.org/ListItem">
<a itemprop="item" href=""><span itemprop="name">pharmaessentia</span></a>
<meta itemprop="position" content="1">
</li>
<li itemprop="itemListElement" itemscope="" itemtype="http://schema.org/ListItem">
<a itemprop="item" href=""><span itemprop="name"></span></a>
<meta itemprop="position" content="2">
</li>
</ol>
</div>
</div>
<footer class="wrap-fs footer">
<div class="wrap">
<p class="copyright">
<span>© PharmaEssentia Corporation.</span>
<span>DESIGN by <a target="_blank" href="https://www.creatop.com.tw">CREATOP. </a></span>
<span><a href="en/sitemap">Site map</a></span>
<span><a href="en/privacy">Privacy policy</a></span>
</p>
</div>
</footer>
</div>
<div id="js-rwd"></div>
<div class="load">
<div class="load-3">
<div class="line"></div>
<div class="line"></div>
<div class="line"></div>
</div>
</div> <script src="assets/js/main.min.js"></script>
<script src="assets/js/slick.min.js"></script>
<script>
$(function () {
$('.news-slide').slick({
vertical: true,
speed: 500,
autoplay: true,
arrows: false,
// accessibility: false,
// initialSlide :true,
// infinite: true,
centerMode:false,
autoplaySpeed: 3000,
responsive: [{
breakpoint: 768,
settings: {
// centerMode: true,
arrows: false,
vertical: true,
speed: 500,
// infinite: true,
autoplay: true,
}
}]
});
return false;
})
</script>
</body></html>